Candel Therapeutics Stock Forecast - Daily Balance Of Power

CADL Stock  USD 5.14  0.24  4.90%   
Candel Stock Forecast is based on your current time horizon. Although Candel Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Candel Therapeutics' systematic risk associated with finding meaningful patterns of Candel Therapeutics fundamentals over time.
  
At this time, Candel Therapeutics' Payables Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0 this year, although the value of Fixed Asset Turnover will most likely fall to 0.02. . The value of Common Stock Shares Outstanding is expected to slide to about 23.2 M. The value of Net Loss is expected to slide to about (17.8 M).
On April 24, 2024 Candel Therapeutics had Daily Balance Of Power of 0.0161. Balance of Power indicator (or BOP) measures the strength of Candel Therapeutics market sensitivity to bulls and bears. It estimates the ability of Candel Therapeutics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Candel Therapeutics Balance of Power indicator one can determine a trend of the price direction.
Check Candel Therapeutics VolatilityBacktest Candel TherapeuticsTrend Details  

Candel Therapeutics Trading Date Momentum

On April 25 2024 Candel Therapeutics was traded for  6.43  at the closing time. The top price for the day was 6.81  and the lowest listed price was  5.74 . The trading volume for the day was 750.6 K. The trading history from April 25, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 6.28% . The overall trading delta against the current closing price is 6.28% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Candel Therapeutics to competition

Other Forecasting Options for Candel Therapeutics

For every potential investor in Candel, whether a beginner or expert, Candel Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Candel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Candel. Basic forecasting techniques help filter out the noise by identifying Candel Therapeutics' price trends.

View Candel Therapeutics Related Equities

 Risk & Return  Correlation

Candel Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Candel Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Candel Therapeutics' current price.

Candel Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Candel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Candel Therapeutics shares will generate the highest return on investment. By undertsting and applying Candel Therapeutics stock market strength indicators, traders can identify Candel Therapeutics entry and exit signals to maximize returns.

Candel Therapeutics Risk Indicators

The analysis of Candel Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Candel Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting candel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Candel Therapeutics is a strong investment it is important to analyze Candel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Candel Therapeutics' future performance. For an informed investment choice regarding Candel Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Candel Therapeutics to cross-verify your projections.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.73)
Revenue Per Share
0.001
Return On Assets
(0.52)
Return On Equity
(4.81)
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.